Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 10 No. 7, July 2009
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Navarro, F.
Right arrow Articles by Quiros-Tejeira, R. E.
PubMed
Right arrow Articles by Navarro, F.
Right arrow Articles by Quiros-Tejeira, R. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

NeoReviews Vol.10 No.7 2009 e330
© 2009 American Academy of Pediatrics

Short Bowel Syndrome

Epidemiology, Pathophysiology, and Adaptation

Fernando Navarro, MD*
Wallace A. Gleason, MD*
J. Marc Rhoads, MD*
Ruben E. Quiros-Tejeira, MD*

* The University of Texas Medical School at Houston and Department of Pediatrics, Children's Memorial Hermann Hospital, Houston, Tex

Short bowel syndrome (SBS) is a relatively common, often lethal, and highly costly medical problem in North America. Necrotizing enterocolitis (NEC) is the leading cause of SBS in the United States. An important fact to remember is that the length of the small bowel in a 28-week preterm infant is about 150 cm and in a term infant is about 250 cm. Twenty percent of this length is generally sufficient to allow dependence on parenteral nutrition (PN) via intestinal adaptation. This process is driven by significant increases in circulating trophic hormones, such as cholecystokinin, epidermal and keratinocyte growth factors, growth hormone, insulin-like growth factor-1, and glucagon-like peptide-2. These hormones produce hypertrophy and hyperplasia of the villi, along with increases in specific brush border membrane absorption mechanisms, such as glucose-sodium cotransport (via SGLT-1) and peptide transport (via Pep-T1). Currently, the best clinical markers of intestinal adaptation are the calculated percentage of enteral versus parenteral calories in a growing infant who has SBS and the serum concentrations of citrulline, an amino acid synthesized by mature enterocytes that has been used as a measure of functional intestinal mass.

Abbreviations: CCK: cholecystokinin • CIT: citrulline • EGF: epidermal growth factor • GLP: glucagon-like peptide • Hb-EGF: heparin-binding epidermal growth factor • ICV: ileocecal valve • IGF: insulin-like growth factor • NEC: necrotizing enterocolitis • NHE: sodium/hydrogen exchanger • PN: parenteral nutrition • PYY: peptide YY • SBL: small bowel length • SBS: short bowel syndrome • SCFA: short-chain fatty acid


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Academy of Pediatrics.